Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme
- PMID: 24798212
- DOI: 10.1002/hec.3058
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme
Abstract
This paper presents an application of a new methodological framework for undertaking distributional cost-effectiveness analysis to combine the objectives of maximising health and minimising unfair variation in health when evaluating population health interventions. The National Health Service bowel cancer screening programme introduced in 2006 is expected to improve population health on average and to worsen population health inequalities associated with deprivation and ethnicity--a classic case of 'intervention-generated inequality'. We demonstrate the distributional cost-effectiveness analysis framework by examining two redesign options for the bowel cancer screening programme: (i) the introduction of an enhanced targeted reminder aimed at increasing screening uptake in deprived and ethnically diverse neighbourhoods and (ii) the introduction of a basic universal reminder aimed at increasing screening uptake across the whole population. Our analysis indicates that the universal reminder is the strategy that maximises population health, while the targeted reminder is the screening strategy that minimises unfair variation in health. The framework is used to demonstrate how these two objectives can be traded off against each other, and how alternative social value judgements influence the assessment of which strategy is best, including judgements about which dimensions of health variation are considered unfair and judgements about societal levels of inequality aversion.
Keywords: cost-effectiveness analysis; equity; health inequality.
© 2014 The Authors. Health Economics published by John Wiley & Sons Ltd.
Similar articles
-
Distributional Cost-Effectiveness Analysis: A Tutorial.Med Decis Making. 2016 Jan;36(1):8-19. doi: 10.1177/0272989X15583266. Epub 2015 Apr 23. Med Decis Making. 2016. PMID: 25908564 Free PMC article.
-
Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered.Cancer Res Treat. 2016 Jul;48(3):1010-9. doi: 10.4143/crt.2015.279. Epub 2015 Dec 28. Cancer Res Treat. 2016. PMID: 26727714 Free PMC article.
-
Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis.Prev Med. 2020 Jan;130:105879. doi: 10.1016/j.ypmed.2019.105879. Epub 2019 Oct 31. Prev Med. 2020. PMID: 31678586
-
Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. J Gen Intern Med. 2012. PMID: 22237663 Free PMC article. Review.
-
Cost-Effectiveness of Current Colorectal Cancer Screening Tests.Gastrointest Endosc Clin N Am. 2020 Jul;30(3):479-497. doi: 10.1016/j.giec.2020.02.005. Epub 2020 Apr 9. Gastrointest Endosc Clin N Am. 2020. PMID: 32439083 Review.
Cited by
-
Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review.Clinicoecon Outcomes Res. 2024 Aug 20;16:581-596. doi: 10.2147/CEOR.S471827. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 39184340 Free PMC article. Review.
-
Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes.Front Pharmacol. 2023 Nov 24;14:1249998. doi: 10.3389/fphar.2023.1249998. eCollection 2023. Front Pharmacol. 2023. PMID: 38074129 Free PMC article.
-
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield.JNCI Cancer Spectr. 2024 Apr 30;8(3):pkae043. doi: 10.1093/jncics/pkae043. JNCI Cancer Spectr. 2024. PMID: 38830030 Free PMC article.
-
Using Cost-Effectiveness Analysis to Address Health Equity Concerns.Value Health. 2017 Feb;20(2):206-212. doi: 10.1016/j.jval.2016.11.027. Value Health. 2017. PMID: 28237196 Free PMC article.
-
HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".Int J Health Policy Manag. 2016 Aug 1;5(8):501-505. doi: 10.15171/ijhpm.2016.59. Int J Health Policy Manag. 2016. PMID: 27694664 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical